Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
Cardiovascular Institute, Azienda Ospedaliero-Universitaria S. Anna and LTTA Center, Ferrara, Italy.
J Mol Cell Cardiol. 2015 Jan;78:142-53. doi: 10.1016/j.yjmcc.2014.08.015. Epub 2014 Aug 27.
The mitochondrial permeability transition is a key event in cell death. Intense research efforts have been focused on elucidating the molecular components of the mitochondrial permeability transition pore (mPTP) to improve the understanding and treatment of various pathologies, including neurodegenerative disorders, cancer and cardiac diseases. Several molecular factors have been proposed as core components of the mPTP; however, further investigation has indicated that these factors are among a wide range of regulators. Thus, the scientific community lacks a clear model of the mPTP. Here, we review the molecular factors involved in the regulation and formation of the mPTP. Furthermore, we propose that the mitochondrial ATP synthase, specifically its c subunit, is the central core component of the mPTP complex. Moreover, we discuss the involvement of the mPTP in ischemia and reperfusion as well as the results of clinical studies targeting the mPTP to ameliorate ischemia-reperfusion injury. This article is part of a Special Issue entitled "Mitochondria: From Basic Mitochondrial Biology to Cardiovascular Disease".
线粒体通透性转换是细胞死亡的一个关键事件。人们已经投入了大量的研究努力来阐明线粒体通透性转换孔(mPTP)的分子组成,以提高对包括神经退行性疾病、癌症和心脏病在内的各种病理的理解和治疗。已经提出了几种分子因素作为 mPTP 的核心组成部分;然而,进一步的研究表明,这些因素是广泛的调节剂之一。因此,科学界缺乏对 mPTP 的明确模型。在这里,我们回顾了参与 mPTP 调节和形成的分子因素。此外,我们提出线粒体 ATP 合酶,特别是其 c 亚基,是 mPTP 复合物的核心组成部分。此外,我们还讨论了 mPTP 在缺血再灌注中的作用以及针对 mPTP 的临床研究结果,以改善缺血再灌注损伤。本文是题为“线粒体:从基础线粒体生物学到心血管疾病”的特刊的一部分。